These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2832985)

  • 1. High chemotactic motility and growth in hard agar of a variant of RSV-transformed fibroblasts are lost in late passages.
    Allavena G; Melchiori A; Carlone S; Di Renzo MF; Comoglio P; Parodi S; Santi L; Albini A
    Tumori; 1988 Feb; 74(1):1-6. PubMed ID: 2832985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organization of cytoskeleton and fibronectin matrix in Rous sarcoma virus (RSV)-transformed fibroblast lines with different metastatic potential.
    Di Renzo MF; Tarone G; Comoglio PM; Marchisio PC
    Eur J Cancer Clin Oncol; 1985 Jan; 21(1):85-96. PubMed ID: 2982623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of stable spontaneous metastatic variant lines of RSV-transformed mouse fibroblasts.
    Di Renzo MF; Bretti S
    Int J Cancer; 1982 Dec; 30(6):751-7. PubMed ID: 6298121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the chemotactic response to conditioned medium of BALB/c3T3 fibroblasts and their SV 40 transformants.
    Albini A; Allavena G; Parodi S; Santi L
    Tumori; 1985 Apr; 71(2):97-100. PubMed ID: 2988166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid characteristics of RSV-transformed Balb/c 3T3 cell lines with different spontaneous metastatic potentials.
    Calorini L; Fallani A; Tombaccini D; Barletta E; Mugnai G; Di Renzo MF; Comoglio PM; Ruggieri S
    Lipids; 1989 Aug; 24(8):685-90. PubMed ID: 2555644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic clones selected from an RSV-induced mouse sarcoma share a common marker chromosome.
    Di Renzo MF; Doneda L; Larizza L; Comoglio PM
    Int J Cancer; 1983 Apr; 31(4):455-61. PubMed ID: 6299976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of neoplastic cells derived from a hamster tumor induced by avian sarcoma virus B77.
    Sabová L; Smida J; Smidová V
    Neoplasma; 1979; 26(6):641-6. PubMed ID: 232249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No expression of a Rous sarcoma virus-induced tumor antigen in mammalian cells infected with retroviruses transducing other oncogenes of the src gene family.
    Kuzumaki N; Yamagiwa S; Oikawa T
    J Natl Cancer Inst; 1985 Apr; 74(4):889-92. PubMed ID: 2985859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of correlation between tumorigenicity and level of plasminogen activator in fibroblasts transformed by Rous sarcoma virus.
    Wolf BA; Goldberg AR
    Proc Natl Acad Sci U S A; 1978 Oct; 75(10):4967-71. PubMed ID: 217007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptors for plasminogen activator, urokinase, in normal and Rous sarcoma virus-transformed mouse fibroblasts.
    Del Rosso M; Dini G; Fibbi G
    Cancer Res; 1985 Feb; 45(2):630-6. PubMed ID: 2981611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced chemotaxis of tumor-derived and virus-transformed cells to fibronectin and fibroblast-conditioned medium.
    Mensing H; Albini A; Krieg T; Pontz BF; Müller PK
    Int J Cancer; 1984 Jan; 33(1):43-8. PubMed ID: 6693193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of the metastatic potential of a RSV-transformed fibroblastic line (B77-AA6 cells) upon transplantation in essential fatty acid-deficient mice.
    Calorini L; Ruggieri S
    Invasion Metastasis; 1992; 12(3-4):233-40. PubMed ID: 1338202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of plasminogen activator activity by the culture medium of Rous sarcoma virus-transformed cells.
    Mignatti P; Barlati S
    J Gen Virol; 1982 Dec; 63(2):365-73. PubMed ID: 6296283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoskeletal changes induced by two avian sarcoma viruses: UR2 and Rous sarcoma virus.
    Notter MF; Balduzzi PC
    Virology; 1984 Jul; 136(1):56-68. PubMed ID: 6330996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein degradation in 3T3 cells and tumorigenic transformed 3T3 cells.
    Gronostajski RM; Pardee AB
    J Cell Physiol; 1984 Apr; 119(1):127-32. PubMed ID: 6323489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse Balb/c3T3 cell mutant with low epidermal growth factor receptor activity: induction of stable anchorage-independent growth by transforming growth factor beta.
    Kuratomi Y; Ono M; Yasutake C; Mawatari M; Kuwano M
    J Cell Physiol; 1987 Jan; 130(1):51-7. PubMed ID: 3468117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rous sarcoma virus mutant dlPA105 induces different transformed phenotypes in quail embryonic fibroblasts and neuroretina cells.
    Poirier F; Laugier D; Marx M; Dambrine G; Garber EA; Genvrin P; David-Pfeuty T; Calothy G
    J Virol; 1987 Aug; 61(8):2530-9. PubMed ID: 3037115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemically and virally transformed cells able to grow without anchorage in serum-free medium: evidence for an autocrine growth factor.
    Xin LW; Jullien P; Lawrence DA; Pironin M; Vigier P
    J Cell Physiol; 1987 May; 131(2):175-83. PubMed ID: 3034920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transformation of rat cerebral endothelial cells by Rous sarcoma virus.
    Diglio CA; Wolfe DE; Meyers P
    J Cell Biol; 1983 Jul; 97(1):15-21. PubMed ID: 6134735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ornithine decarboxylase induction during B1 progression of normal and Rous sarcoma virus-transformed cells.
    Haddox MK; Magun BE; Russell DH
    Cancer Res; 1980 Mar; 40(3):604-8. PubMed ID: 6258784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.